Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates
July 09, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced...
Vericel Announces Submission of Biologics License Application to the FDA for NexoBrid for the Treatment of Severe Thermal Burns
June 30, 2020 07:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
Vericel to Present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020
May 13, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Reports First Quarter 2020 Financial Results
May 05, 2020 08:00 ET
|
Vericel Corporation
Product Revenues of $26.7 Million Increase 22% Over First Quarter 2019 Positive Cash Flow for the Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 05, 2020 (GLOBE...
Vericel to Report First-Quarter 2020 Financial Results on May 5, 2020
April 22, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the...
Vericel Announces Change to a Virtual Meeting Format For 2020 Annual Meeting of Shareholders
April 10, 2020 09:00 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 10, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that as a...
Vericel to Present at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, 2020
April 08, 2020 08:30 ET
|
Vericel Corporation
CAMBRIDGE, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...
Vericel Provides Business and Financial Updates
April 02, 2020 09:00 ET
|
Vericel Corporation
First Quarter Preliminary Unaudited Product Revenues Increased Approximately 21% Over First Quarter 2019 Full Year 2020 Financial Guidance Withdrawn Due to Uncertainty Regarding Impact of COVID-19...
Vericel Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Full-Year 2020 Financial Guidance
February 25, 2020 08:00 ET
|
Vericel Corporation
Full Year 2019 Product Revenues of $117.9 Million Increased 30% Over 2018 Record Quarterly Revenue and Profit in the Fourth Quarter Conference Call Today at 8:30am Eastern Standard...
Vericel to Present at the 40th Annual Cowen Healthcare Conference on Monday, March 2, 2020
February 24, 2020 10:04 ET
|
Vericel Corporation
CAMBRIDGE, Mass., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick...